This results suggest that the probability that Monepantel is irrelevant to survival benefits is less than 0.062%.
NUZ should have IND within 30 days from the submission in the next couple of days. I don’t imagine a clinical hold so straight into trials.
still think we will go cheap in the end someone will swoop up early if P2 readouts are even half as good as OLE.
Ann: Positive 8-month Interim Data from OLE Study, page-50
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.005(3.13%) |
Mkt cap ! $81.23M | |||
| Open | High | Low | Value | Volume |
| 16.0¢ | 17.0¢ | 15.5¢ | $193.8K | 1.191M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 78264 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 49399 | 3 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |